ÂÜÀòÂÒÂ×

Carlos Núñez Otero, Ph.D. has a diverse work experience. In 2021, they began working at Mycorena as a TechMyc Manager, Research and Development Scientist, and R&D Engineer. From 2015 to 2018, they worked at Umeå University as a PhD Student, Research Assistant, Master Thesis Project, and Research Fellow. During their PhD, they evaluated and developed 2-pyridone compounds by Structure Activity Relationship (SAR) and studied their role as potential drugs for treatment of Chlamydia trachomatis infections. As a Research Assistant, they evaluated the inhibitory effect of small molecules in Gram positive bacteria (MRSA and E. faecalis). As a Master Thesis Project, they collaborated with the department of chemistry and clinical microbiology. As a Research Fellow, they performed a screening of a library of small molecules in Chlamydia trachomatis followed by EC50 calculations of 4 small molecules and contributed to the plaque purification of mutants resistant to a class of small molecules. In 2018, they worked at the Robert Koch Institute as a Research Stay, where they learned a method to isolate intact inclusions of Chlamydia trachomatis and applied affinity chromatography to identify the target of different small molecules. In 2014, they worked at Umeå University as a Research Fellow, where they developed a new method to screen Chlamydia trachomatis in high throughput assays based on plasmid cloning and transformation, did a screening of a library of small molecules in Chlamydia trachomatis by using automated microscope Arrayscan, and purified Chlamydia mutants by plaque assays and sequenced their genome to detect mutations.

Carlos Núñez Otero, Ph.D. graduated with a Bachelor's Degree in Biology/Biological Sciences, General from Universidad de Alcalá in 2014. Carlos then went on to obtain a Master's Degree in Molecular Biology from Umeå University in 2016. In 2020, they earned a Doctor of Philosophy - PhD in Clinical Microbiology from Umeå University.